Literature DB >> 9643535

Foetal liver infusion in a chronic myeloid leukemia patient with busulphan toxicity.

S Sharma1, V Kochupillai, H P Pati.   

Abstract

A 36-year-old man suffering from chronic myeloid leukemia (in chronic phase) was initially treated with busulphan. At the end of 6 months of follow-up he developed bone marrow aplasia. He was given single foetal liver infusion therapy. The patient recovered fully from aplasia. He continued in chronic phase for more than 7 years with intermittent busulphan therapy.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9643535     DOI： 10.1007/bf02787349

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  10 in total

1.  Granulocytic progenitor cells in aplastic anaemia.

Authors:  P Kern; H Heimpel; W Heit; B Kubanek
Journal:  Br J Haematol       Date:  1977-04       Impact factor: 6.998

Review 2.  The chemical and biological properties of busulphan ("Myleran").

Authors:  C D Dunn
Journal:  Exp Hematol       Date:  1974       Impact factor: 3.084

3.  Delayed toxic effect of busulfan on the marrow.

Authors:  O P Ganda; A Mangalik
Journal:  J Assoc Physicians India       Date:  1973-06

4.  Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.

Authors:  M P Gollerkeri; G B Shah
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

5.  Fetal liver transplantation in immunodeficiencies and inborn errors of metabolism.

Authors:  J L Touraine; M G Roncarolo; G L Marseglia; G Souillet; B Bétend; H Bétuel; F Touraine; C Royo; N Philippe; R François
Journal:  Prog Clin Biol Res       Date:  1985

6.  Fetal liver infusion in aplastic anaemia.

Authors:  V Kochupillai; S Sharma; S Francis; A Nanu; S Mathew; P Bhatia; H Dua; L Kumar; S Aggarwal; S Singh
Journal:  Thymus       Date:  1987

7.  Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis.

Authors:  N J Wareham; S A Johnson; J M Goldman
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Fetal liver transplantation in aplastic anemia and leukemia.

Authors:  R P Gale
Journal:  Thymus       Date:  1987

Review 9.  Aplastic anemia: biology and treatment.

Authors:  R P Gale; R E Champlin; S A Feig; J H Fitchen
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

10.  Hemopoietic improvement following fetal liver infusion in aplastic anemia.

Authors:  V Kochupillai; S Sharma; K R Sundaram; R K Ahuja
Journal:  Eur J Haematol       Date:  1991-11       Impact factor: 2.997
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.